Page 78

Rev Nutr 43-4

407 Caracterización física, nutricional y no nutricional de las semillas de Inga paterno 42. Srivastava, R. and H. Vasishtha, Saponins and lectins of Indian chickpeas (Cicer arietinum) and lentils (Lens culinaris). Indian J Agricul Biochem, 2012. 25(1): p. 44-7. 43. Shi, J., et al., Saponins from edible legumes: chemistry, processing, and health benefits. J Medi Food, 2004. 7(1): 67-78. 44. Valdez-Anguiano, D.M., et al., Changes of Phenolic Compounds and Antioxidant Activity Induced by Germination of Vicia faba, in Seeds as Functional Foods and Nutraceuticals2014. p. 143-56. 45. Saini, H.S., Legume seed oligosaccharides, in Recent Advances of Research in Antinutritional Factors in Legume Seeds, J. Huisman, Van der Poel, T. F. B., Liener, I. E., Editor 1989. p. 329–341. 46. Cristofaro, E., F. Mottu, and J. Wuhrmann, Involvement of the raffinose family of oligosaccharides in flatulence. Sugars in Nutrition. HL Sipple & KW McNutt, eds, 1974. 47. Schneider, A.V., Overview of the market and consumption of puises in Europe. British J Nutr. 2002. 88(S3): 243-50. 48. Eiwegger, T., et al., Human milk–derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatric Res, 2004. 56(4): 536-40. 49. Swanson, K., et al., Effects of Supplemental Fructooligosaccharides Plus Mannanoligosaccharides on Immune Function and Ileal and Fecal Microbial Populations in Adult Dogs. Archiv für Tierernaehrung, 2002. 56(4): 309-18. 50. Buddington, R., et al., Non–digestible oligosaccharides and defense functions: lessons learned from animal models. British J Nutr. 2002. 87(S2): S231-9. 51. Lindsay, J.O., et al., Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease. Gut, 2006. 55(3): p. 348-355. 52. Bruzzese, E., et al., Impact of prebiotics on human health. Digestive Liver Dis, 2006. 38: S283-S87. 53. Oddy, W.H., The impact of breastmilk on infant and child health. Breastfeeding Rev, 2002. 10(3): 5. 54. Kaur, N. and A.K. Gupta, Applications of inulin and oligofructose in health and nutrition. J Biosci, 2002. 27(7): 703-14. 55. Stahl, B., L. M’Rabet, and A. Vos, Immunomodulating oligosaccharides, and therapeutic use there of. Int. Patent WO, 2005. 2: 005-039. 56. Guillamón, E., et al., The trypsin inhibitors present in seed of different grain legume species and cultivar. Food Chem. 2008.; 107(1): 68-74. 57. Norton, G., Proteinase inhibitors, in Toxic Substances in Crop Plants, J.P.F. D’Mello, Duffus, C.M., Duffus, J.H., Editor 1991, Toxic Substances in Crop Plants. The Royal Society of Chemistry: Cambridge. p. 68-106. 58. Kennedy, A.R., The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. The Am J Clini Nutr. 1998. 68(6): 1406S-2S. 59. Vidal-Valverde, C., et al., Influence of Processing on Trypsin Inhibitor Activity of Faba Beans and Its Physiological Effect. J Agricul Food Chem, 1997. 45(9): 3559-64. 60. Alonso, R., A. Aguirre, and F. Marzo, Effects of extrusion and traditional processing methods on antinutrients and in vitro digestibility of protein and starch in faba and kidney beans. Food Chem, 2000. 68(2): 159-65.


Rev Nutr 43-4
To see the actual publication please follow the link above